Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is a subset of breast cancer with aggressive characteristics and few therapeutic options. The lack of an appropriate therapeutic target is a challenging issue in treating TNBC. Although a high level expression of epidermal growth factor receptor (EGFR) has been a...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Kyu Sic, Yi, Yong Weon, Cho, Jeonghee, Park, Jeong-Soo, Seong, Yeon-Sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233743/
https://www.ncbi.nlm.nih.gov/pubmed/34207383
http://dx.doi.org/10.3390/ph14060589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233743/
https://www.ncbi.nlm.nih.gov/pubmed/34207383
http://dx.doi.org/10.3390/ph14060589

Ejemplares similares